These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 13496278)

  • 1. [Amorphous and crystalline trypsin preparations in the therapy of chronic suppurative diseases of the lung and pleura].
    KOVACS K
    Tuberkulozis; 1957; 10(5-6):137-42. PubMed ID: 13496278
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary report on the radiologic evaluation of trypsin in certain chronic chest diseases.
    SILBERT NE
    Dis Chest; 1959 Feb; 35(2):162-9. PubMed ID: 13630196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Repeated operations on the lungs and pleura in suppurative diseases].
    Zemskov NN; Levina VP; Dugel'nyĭ VS; Arbuzov VN; Iakovleva IM
    Klin Khir (1962); 1978 Sep; (9):9-13. PubMed ID: 703101
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of proteolytic enzymes in the surgical management of pulmonary and pleural diseases and in the treatment of suppurative wounds].
    Pilipchuk NS; Beremeenko KN
    Khirurgiia (Mosk); 1966 Nov; 42(11):92-5. PubMed ID: 6002549
    [No Abstract]   [Full Text] [Related]  

  • 5. Thoracic pain of pleural, pulmonary and diaphragmatic origin.
    HODGSON CH
    Proc Staff Meet Mayo Clin; 1956 Jan; 31(1):21-4. PubMed ID: 13280752
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chest pain of pleuro-pulmonary origin].
    BROCARD H; CHOFFEL C
    Vie Med; 1956 Jul; 37(7):863-7. PubMed ID: 13381056
    [No Abstract]   [Full Text] [Related]  

  • 7. SIMULATED INFILTRATION OF THE LUNG DUE TO PLEURAL THICKENING.
    GORDON SS; GILCHRIST M
    Am J Roentgenol Radium Ther Nucl Med; 1964 Dec; 92():1373-9. PubMed ID: 14237495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Corticoid therapy during pleuropulmonary disorders].
    BRUN J
    J Med Lyon; 1959 Jul-Aug 20; 40(498):629-34. PubMed ID: 13805269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ultrasonic technologies in diagnosis and treatment of patients with surgical diseases of lungs and pleura].
    Pavlov IuV; Ablitsov IuA; Chistov LV; Kharnas SS; Rybin VK; Ablitsov AIu
    Khirurgiia (Mosk); 2003; (8):30-4. PubMed ID: 13677985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Supplemental parenteral feeding after operations in suppurative diseases of the lungs and pleura].
    Alekseeva ME; Lagoda VV
    Grudn Khir; 1981; (1):67-70. PubMed ID: 6781988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzymes in bronchopulmonary therapy].
    SUAREZ DIAZ E
    Rev Med Cubana; 1959 Jan; 70(1):14-23. PubMed ID: 13634626
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hemosorption on immunological reactivity indices in the combined treatment of patients with extensive nonspecific destructive suppurative processes in the lungs and pleura].
    Lukomskiĭ GI; Belokrinitskiĭ DV; Saakian NA; Shelepin AA; Kudriavitskiĭ AI
    Grudn Khir; 1985; (2):20-3. PubMed ID: 3988106
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantages and disadvantages of Seldniger transthoracic drainage in purulent-destructive diseases of the lung and pleura in childhood.
    Ivanov B; Stefanova P
    Khirurgiia (Sofiia); 2014; (3):25-7. PubMed ID: 25799620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trypsin as an aerosol and in intrapleural administration].
    GERRITS JC; GROEN AS
    Ned Tijdschr Geneeskd; 1955 Sep; 99(36):2632-7. PubMed ID: 13265873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute non-tuberculous pleural & pulmonary diseases with phenylbutazone].
    ISEMEIN L; NICOLINO J
    Mars Med; 1957; 94(8):537-41. PubMed ID: 13482467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hemosorption on the central hemodynamics, oxygen transport, tissue respiration and the metabolic indices of patients with suppurative destructive processes in the lungs and pleura].
    Lopatin AF; Monin MI; Sukhotin SK
    Grudn Khir; 1986; (6):63-5. PubMed ID: 3804006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver and kidney functions after therapeutic plasmaphereses in the treatment of acute destructive diseases of the lungs and pleura].
    Fedoseĭkin IV
    Fiziol Cheloveka; 2006; 32(1):115-7. PubMed ID: 16526299
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic plasmapheresis and extracorporeal low-flow blood oxygenation in the combined treatment of patients with acute suppurative-septic lesions of the lungs and pleura].
    Shalaev SA; Kaleko SP; Bel'skikh AN; Tulupov AN; Popov VI; Zhukov OI; Men'shikova EA
    Vestn Khir Im I I Grek; 1993; 150(1-2):86-90. PubMed ID: 7701714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune nature of the nephropathy in suppurative diseases of the lungs and pleura].
    Ryff IM; Sokolova RI; Zhigalkin GV
    Arkh Patol; 1974; 36(1):23-30. PubMed ID: 4615661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of low frequency ultrasonic technology in preventing and treating purulent wounds of the lung and pleura].
    Pavlov IuV
    Khirurgiia (Mosk); 2002; (5):64-7. PubMed ID: 12077841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.